Victor G Vogel. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » AdultAge FactorsAgedAnticarcinogenic Agents/therapeutic useBiomarkers, Tumor/metabolismBone Density/drug effectsBone Density Conservation Agents/therapeutic useBreast Neoplasms/epidemiologyBreast Neoplasms/metabolismBreast Neoplasms/prevention & controlConfounding Factors, EpidemiologicEstradiol/bloodFemaleFractures, Bone/etiologyFractures, Bone/prevention & controlHumansIncidenceMiddle AgedOsteoporosis, Postmenopausal/complicationsPrimary Prevention/methodsPyrrolidines/therapeutic useRaloxifene Hydrochloride/therapeutic useRisk AssessmentSample SizeSelective Estrogen Receptor Modulators/therapeutic useTetrahydronaphthalenes/therapeutic useTreatment Outcome
Substances： See more » Anticarcinogenic AgentsBiomarkers, TumorBone Density Conservation AgentsPyrrolidinesSelective Estrogen Receptor ModulatorsTetrahydronaphthalenesLasofoxifeneRaloxifene HydrochlorideEstradiol
Year: 2010 PMID： 21051657 DOI： 10.1093/jnci/djq435
Source DB: PubMed Journal: J Natl Cancer Inst ISSN： 0027-8874 Impact factor: 13.506